about
Radiosynthesis and first preclinical evaluation of the novel norepinephrine transporter pet-ligand [(11)C]ME@HAPTHINew approaches for the reliable in vitro assessment of binding affinity based on high-resolution real-time data acquisition of radioligand-receptor binding kineticsImaging biomarkers or biomarker imaging?Pgp-mediated interaction between (R)-[11C]verapamil and tariquidar at the human blood-brain barrier: a comparison with rat dataExploring the impact of BDNF Val66Met genotype on serotonin transporter and serotonin-1A receptor bindingIn vivo P-glycoprotein function before and after epilepsy surgery.Reduced serotonin-1A receptor binding in social anxiety disorder.[18F]FE@SUPPY: a suitable PET tracer for the adenosine A3 receptor? An in vivo study in rodentsEffects of Silexan on the serotonin-1A receptor and microstructure of the human brain: a randomized, placebo-controlled, double-blind, cross-over study with molecular and structural neuroimaging.Development of potential selective and reversible pyrazoline based MAO-B inhibitors as MAO-B PET tracer precursors and reference substances for the early detection of Alzheimer's disease.Hide and seek: a comparative autoradiographic in vitro investigation of the adenosine A3 receptorDifferential modulation of the default mode network via serotonin-1A receptorsEffects of norepinephrine transporter gene variants on NET binding in ADHD and healthy controls investigated by PETMultiparametric [18F]Fluorodeoxyglucose/ [18F]Fluoromisonidazole Positron Emission Tomography/ Magnetic Resonance Imaging of Locally Advanced Cervical Cancer for the Non-Invasive Detection of Tumor Heterogeneity: A Pilot Study.High-Dose Testosterone Treatment Increases Serotonin Transporter Binding in Transgender People.[¹⁸F]FE@SNAP-A new PET tracer for the melanin concentrating hormone receptor 1 (MCHR1): microfluidic and vessel-based approachesChanges in Tumor Biology During Chemoradiation of Cervix Cancer Assessed by Multiparametric MRI and Hypoxia PET.The norepinephrine transporter in attention-deficit/hyperactivity disorder investigated with positron emission tomography.Global decrease of serotonin-1A receptor binding after electroconvulsive therapy in major depression measured by PET.[(18)F]FE@SNAP-a specific PET tracer for melanin-concentrating hormone receptor 1 imaging?Preparation and First Preclinical Evaluation of [(18)F]FE@SNAP: A Potential PET Tracer for the Melanin-Concentrating Hormone Receptor-1 (MCHR1)What to consider in the development of new bone seekers: mechanistic and tracer-related aspects.[18F]Ciprofloxacin, a new positron emission tomography tracer for noninvasive assessment of the tissue distribution and pharmacokinetics of ciprofloxacin in humans.[18F]FMeNER-D2: reliable fully-automated synthesis for visualization of the norepinephrine transporter.Effects of Selective Serotonin Reuptake Inhibitors on Interregional Relation of Serotonin Transporter Availability in Major Depression.Effects of hormone replacement therapy on cerebral serotonin-1A receptor binding in postmenopausal women examined with [carbonyl-¹¹C]WAY-100635.The influence of the rs6295 gene polymorphism on serotonin-1A receptor distribution investigated with PET in patients with major depression applying machine learning.In vivo magnetic resonance imaging of pancreatic tumors using iron oxide nanoworms targeted with PTR86 peptide.LogP, a yesterday's value?Simple and rapid quantification of serotonin transporter binding using [11C]DASB bolus plus constant infusion.Association of Protein Distribution and Gene Expression Revealed by PET and Post-Mortem Quantification in the Serotonergic System of the Human Brain.[(18)F]FMeNER-D2: A systematic in vitro analysis of radio-metabolism.Hypothalamic serotonin-1A receptor binding measured by PET predicts the plasma level of dehydroepiandrosterone sulfate in healthy women.18F fluoroethylations: different strategies for the rapid translation of 11C-methylated radiotracers.Pre vivo, ex vivo and in vivo evaluations of [68Ga]-EDTMP.Multiparametric [11C]Acetate positron emission tomography-magnetic resonance imaging in the assessment and staging of prostate cancerThe value of [11C]-acetate PET and [18F]-FDG PET in hepatocellular carcinoma before and after treatment with transarterial chemoembolization and bevacizumab.Some new methods for the synthesis of cardiac neurotransmission PET radiotracers.In vivo evaluation of radiotracers targeting the melanin-concentrating hormone receptor 1: [11C]SNAP-7941 and [18F]FE@SNAP reveal specific uptake in the ventricular system.**-Postprandial pancreatic [11C]methionine uptake after pancreaticoduodenectomy mirrors basal beta cell function and insulin release
P50
Q21999407-863A7746-02BA-4DBA-9A02-B6A61A83B315Q31172470-2B1A05DD-E6EB-49A0-8F70-607012DDA6C2Q33963108-65C13916-2F9F-40A8-B1DE-535E57BF8471Q34100185-E8340DD5-F014-4C90-A863-95EFB175D8C1Q34134231-2CE2CF54-54A9-43D5-809A-FD63859ED15AQ34303793-7241930E-18FE-48E7-B0F4-53ADEBED60D8Q34566534-1482BD12-4191-4460-A54D-0BE2DDDF324FQ35148312-296787A8-8ED6-438D-B9D8-61D0D1786E3FQ35178976-0B6A83F1-832C-4E50-B94C-63749C1A53A7Q35225960-4BD752BF-1A2D-41AF-B507-E6EC5CA4FCA7Q35244188-3B736A91-DE65-4251-943E-BF4802D31744Q35787090-A9CD1E46-2029-419C-97F9-90C17E161D60Q35871702-6C6224B8-0BD0-46DE-96AB-3DF2A853B52DQ36014483-9630FEB0-E924-4410-8BB3-B2CE17E1CE93Q36098853-AE9D3AA1-DAF7-4459-8791-1ADAE43328CBQ36285532-6EED56CD-1B99-4D92-B667-87646A6AC375Q36379633-94510EDD-F0A7-4060-9C31-6018D32C9620Q36424492-76D16B46-A27F-472A-8C5E-9D5D8BC6E4FEQ36479050-EB3CEA26-987E-4C1B-A751-731162437A8AQ36754446-CBBC2D35-4803-44FC-A2BF-A2C861DC5A89Q37218935-DAEF98CD-535D-4603-8F88-65711D6E112EQ37332421-F19AD16D-48CD-4830-A0E2-D017CBECC604Q37568411-B84208E7-27D8-4427-8AFF-ED81257AED56Q37572635-B09618B5-F807-40D6-8895-AADB1496E8BEQ37625437-3A5CAA51-3067-4E15-95B1-05F760CD1924Q38430002-8AA045FB-82CF-49DD-9E8D-9D9E3A9C6F6AQ38671559-E558F10E-2B9A-4FAB-B16F-DEB7C12DE4E4Q38673651-CC3835DF-6B16-4C99-890C-A246E448769FQ38863368-21609996-6CCF-4E76-A6C9-C076B6519F47Q39001294-28510D7B-854F-409A-809D-59A7C05F4D52Q39138127-D85822B4-5169-485E-BE8F-41F3AEEA6154Q39728618-162C09AD-8341-4896-B765-30C4694E50DFQ39882028-FBF0138D-C19A-4748-92B6-27429318C001Q40155081-4F4FBBDB-DE1D-48D7-AE93-0E016F3B203DQ40213366-E8FA5B5F-0FC5-4D8F-BAEA-C818FA055C64Q40487460-BA9671DE-095C-4562-8528-E5E2C21FD8A8Q41192134-B790F659-0637-4B00-85D9-F795B45CB148Q41317962-36FDEA08-19F7-4610-830D-67046087A732Q41388723-B843DC62-E278-4014-8C00-B5C88FC2B816Q41463695-E7FC9D11-11B5-4F94-8E61-9C2F6F01DA7B
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Markus Mitterhauser
@ast
Markus Mitterhauser
@en
Markus Mitterhauser
@es
Markus Mitterhauser
@nl
type
label
Markus Mitterhauser
@ast
Markus Mitterhauser
@en
Markus Mitterhauser
@es
Markus Mitterhauser
@nl
prefLabel
Markus Mitterhauser
@ast
Markus Mitterhauser
@en
Markus Mitterhauser
@es
Markus Mitterhauser
@nl
P106
P1153
7003918510
P21
P2456
P31
P496
0000-0003-3173-5272